Nicholas David Tyrrell

Title: Nicholas David Tyrrell: Innovator in Pyrimidine Modulators

Introduction

Nicholas David Tyrrell is a notable inventor based in West Sussex, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of glucocorticoid receptor modulators. His innovative work has led to the filing of a patent that showcases his expertise and dedication to advancing pharmaceutical science.

Latest Patents

Nicholas David Tyrrell holds a patent for a method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators. The patent details methods for synthesizing 2-amino-6-((1r,4r)-4-phenylcyclohexyl)-5-(3-(trifluoromethyl)benzyl)pyrimidin-4(3H)-one, and its monohydrate form, along with new intermediate compounds. This invention represents a significant advancement in the preparation of compounds that may have therapeutic applications.

Career Highlights

Nicholas is associated with Corcept Therapeutics Incorporated, a company known for its focus on developing innovative treatments for various medical conditions. His work at Corcept has allowed him to contribute to the advancement of new therapeutic strategies, particularly in the realm of glucocorticoid receptor modulation.

Collaborations

Throughout his career, Nicholas has collaborated with esteemed colleagues, including Jeffrey Mark Dener and Hazel Joan Hunt. These collaborations have fostered a productive environment for innovation and have contributed to the success of their projects.

Conclusion

Nicholas David Tyrrell is a distinguished inventor whose work in pyrimidine modulators has the potential to impact the pharmaceutical industry significantly. His patent and contributions to Corcept Therapeutics Incorporated highlight his role as a key player in advancing medicinal chemistry.